Accelerating the study of new drugs for HIV in pregnant and breastfeeding women: A call to action

December 9, 2021
Nurse attending to pregnant woman

More than 19 million women are living with HIV worldwide and the majority are of childbearing potential. There is a public health imperative to ensure that these women can make informed choices about the drugs they take for HIV treatment or prevention. Information to support optimal antiretroviral drug choices in pregnancy has rarely been available for women or their health providers, largely due to historically protectionist and conservative approaches to clinical studies conducted in pregnant and breastfeeding women.
View the research, and read the meeting report.